Selected research
Market Analysis & Forecast
Global Indomethacin Market Analysis and Forecast 2026-2032
Market perspective
The global Indomethacin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Indomethacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Indomethacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Indomethacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Indomethacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Indomethacin include Xinhua Pharma, Merck, Ratiopharm, Ouyi Pharma, Konch Pharma and Hotai Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Indomethacin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Indomethacin, also provides the sales of main regions and countries. Of the upcoming market potential for Indomethacin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Indomethacin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Indomethacin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Indomethacin sales, projected growth trends, production technology, application and end-user industry.
Indomethacin Segment by Company
Xinhua Pharma
Merck
Ratiopharm
Ouyi Pharma
Konch Pharma
Hotai Pharma
Indomethacin Segment by Type
Indomethacin Capsule
Indomethacin Tablet
Indomethacin Suppository
Others
Indomethacin Segment by Application
Children
Adults
Indomethacin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indomethacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Indomethacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indomethacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Indomethacin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Indomethacin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Indomethacin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Indomethacin Capsule
- Indomethacin Tablet
- Indomethacin Suppository
- Others
Applications
- Children
- Adults
Companies covered
- Xinhua Pharma
- Merck
- Ratiopharm
- Ouyi Pharma
- Konch Pharma
- Hotai Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Indomethacin Market by Type
- 1.2.1 Global Indomethacin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Indomethacin Capsule
- 1.2.3 Indomethacin Tablet
- 1.2.4 Indomethacin Suppository
- 1.2.5 Others
- 1.3 Indomethacin Market by Application
- 1.3.1 Global Indomethacin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Children
- 1.3.3 Adults
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Indomethacin Market Dynamics
- 2.1 Indomethacin Industry Trends
- 2.2 Indomethacin Industry Drivers
- 2.3 Indomethacin Industry Opportunities and Challenges
- 2.4 Indomethacin Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Indomethacin Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Indomethacin Revenue by Region
- 3.2.1 Global Indomethacin Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Indomethacin Revenue by Region (2021-2026)
- 3.2.3 Global Indomethacin Revenue by Region (2027-2032)
- 3.2.4 Global Indomethacin Revenue Market Share by Region (2021-2032)
- 3.3 Global Indomethacin Sales Estimates and Forecasts 2021-2032
- 3.4 Global Indomethacin Sales by Region
- 3.4.1 Global Indomethacin Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Indomethacin Sales by Region (2021-2026)
- 3.4.3 Global Indomethacin Sales by Region (2027-2032)
- 3.4.4 Global Indomethacin Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Indomethacin Revenue by Manufacturers
- 4.1.1 Global Indomethacin Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Indomethacin Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Indomethacin Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Indomethacin Sales by Manufacturers
- 4.2.1 Global Indomethacin Sales by Manufacturers (2021-2026)
- 4.2.2 Global Indomethacin Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Indomethacin Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Indomethacin Sales Price by Manufacturers (2021-2026)
- 4.4 Global Indomethacin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Indomethacin Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Indomethacin Manufacturers, Product Type & Application
- 4.7 Global Indomethacin Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Indomethacin Market CR5 and HHI
- 4.8.2 2025 Indomethacin Tier 1, Tier 2, and Tier 3
5 Indomethacin Market by Type
- 5.1 Global Indomethacin Revenue by Type
- 5.1.1 Global Indomethacin Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Indomethacin Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Indomethacin Revenue Market Share by Type (2021-2032)
- 5.2 Global Indomethacin Sales by Type
- 5.2.1 Global Indomethacin Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Indomethacin Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Indomethacin Sales Market Share by Type (2021-2032)
- 5.3 Global Indomethacin Price by Type
6 Indomethacin Market by Application
- 6.1 Global Indomethacin Revenue by Application
- 6.1.1 Global Indomethacin Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Indomethacin Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Indomethacin Revenue Market Share by Application (2021-2032)
- 6.2 Global Indomethacin Sales by Application
- 6.2.1 Global Indomethacin Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Indomethacin Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Indomethacin Sales Market Share by Application (2021-2032)
- 6.3 Global Indomethacin Price by Application
7 Company Profiles
- 7.1 Xinhua Pharma
- 7.1.1 Xinhua Pharma Company Information
- 7.1.2 Xinhua Pharma Business Overview
- 7.1.3 Xinhua Pharma Indomethacin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Xinhua Pharma Indomethacin Product Portfolio
- 7.1.5 Xinhua Pharma Recent Developments
- 7.2 Merck
- 7.2.1 Merck Company Information
- 7.2.2 Merck Business Overview
- 7.2.3 Merck Indomethacin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck Indomethacin Product Portfolio
- 7.2.5 Merck Recent Developments
- 7.3 Ratiopharm
- 7.3.1 Ratiopharm Company Information
- 7.3.2 Ratiopharm Business Overview
- 7.3.3 Ratiopharm Indomethacin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Ratiopharm Indomethacin Product Portfolio
- 7.3.5 Ratiopharm Recent Developments
- 7.4 Ouyi Pharma
- 7.4.1 Ouyi Pharma Company Information
- 7.4.2 Ouyi Pharma Business Overview
- 7.4.3 Ouyi Pharma Indomethacin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Ouyi Pharma Indomethacin Product Portfolio
- 7.4.5 Ouyi Pharma Recent Developments
- 7.5 Konch Pharma
- 7.5.1 Konch Pharma Company Information
- 7.5.2 Konch Pharma Business Overview
- 7.5.3 Konch Pharma Indomethacin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Konch Pharma Indomethacin Product Portfolio
- 7.5.5 Konch Pharma Recent Developments
- 7.6 Hotai Pharma
- 7.6.1 Hotai Pharma Company Information
- 7.6.2 Hotai Pharma Business Overview
- 7.6.3 Hotai Pharma Indomethacin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Hotai Pharma Indomethacin Product Portfolio
- 7.6.5 Hotai Pharma Recent Developments
8 North America
- 8.1 North America Indomethacin Market Size by Type
- 8.1.1 North America Indomethacin Revenue by Type (2021-2032)
- 8.1.2 North America Indomethacin Sales by Type (2021-2032)
- 8.1.3 North America Indomethacin Price by Type (2021-2032)
- 8.2 North America Indomethacin Market Size by Application
- 8.2.1 North America Indomethacin Revenue by Application (2021-2032)
- 8.2.2 North America Indomethacin Sales by Application (2021-2032)
- 8.2.3 North America Indomethacin Price by Application (2021-2032)
- 8.3 North America Indomethacin Market Size by Country
- 8.3.1 North America Indomethacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Indomethacin Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Indomethacin Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Indomethacin Market Size by Type
- 9.1.1 Europe Indomethacin Revenue by Type (2021-2032)
- 9.1.2 Europe Indomethacin Sales by Type (2021-2032)
- 9.1.3 Europe Indomethacin Price by Type (2021-2032)
- 9.2 Europe Indomethacin Market Size by Application
- 9.2.1 Europe Indomethacin Revenue by Application (2021-2032)
- 9.2.2 Europe Indomethacin Sales by Application (2021-2032)
- 9.2.3 Europe Indomethacin Price by Application (2021-2032)
- 9.3 Europe Indomethacin Market Size by Country
- 9.3.1 Europe Indomethacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Indomethacin Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Indomethacin Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Indomethacin Market Size by Type
- 10.1.1 China Indomethacin Revenue by Type (2021-2032)
- 10.1.2 China Indomethacin Sales by Type (2021-2032)
- 10.1.3 China Indomethacin Price by Type (2021-2032)
- 10.2 China Indomethacin Market Size by Application
- 10.2.1 China Indomethacin Revenue by Application (2021-2032)
- 10.2.2 China Indomethacin Sales by Application (2021-2032)
- 10.2.3 China Indomethacin Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Indomethacin Market Size by Type
- 11.1.1 Asia Indomethacin Revenue by Type (2021-2032)
- 11.1.2 Asia Indomethacin Sales by Type (2021-2032)
- 11.1.3 Asia Indomethacin Price by Type (2021-2032)
- 11.2 Asia Indomethacin Market Size by Application
- 11.2.1 Asia Indomethacin Revenue by Application (2021-2032)
- 11.2.2 Asia Indomethacin Sales by Application (2021-2032)
- 11.2.3 Asia Indomethacin Price by Application (2021-2032)
- 11.3 Asia Indomethacin Market Size by Country
- 11.3.1 Asia Indomethacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Indomethacin Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Indomethacin Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Indomethacin Market Size by Type
- 12.1.1 SAMEA Indomethacin Revenue by Type (2021-2032)
- 12.1.2 SAMEA Indomethacin Sales by Type (2021-2032)
- 12.1.3 SAMEA Indomethacin Price by Type (2021-2032)
- 12.2 SAMEA Indomethacin Market Size by Application
- 12.2.1 SAMEA Indomethacin Revenue by Application (2021-2032)
- 12.2.2 SAMEA Indomethacin Sales by Application (2021-2032)
- 12.2.3 SAMEA Indomethacin Price by Application (2021-2032)
- 12.3 SAMEA Indomethacin Market Size by Country
- 12.3.1 SAMEA Indomethacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Indomethacin Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Indomethacin Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Indomethacin Value Chain Analysis
- 13.1.1 Indomethacin Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Indomethacin Production Mode & Process
- 13.2 Indomethacin Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Indomethacin Distributors
- 13.2.3 Indomethacin Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst